PON-P2 |
PON-P2 predicts the pathogenicity (harmfulness) of amino acid substitutions. It is a machine learning-based approach and utilizes amino acid features, Gene Ontology (GO) annotations, evolutionary conservation, and if available, annotations of functional sites. Note that, PON-P2 is NOT a meta-predictor. PON-P2 estimates the reliability of predictions and groups the variants into pathogenic, neutral and unknown classes. Read more Performance of PON-P2 has been extensively tested. For details, see here. Performance of PON-P2 on additional datasets such as predictSNPSelected and SwissVarSelected datasets are also available here. PON-P2 has been shown to work also on cancer variants. PON-P2 predictions for amino acid substitutions in COSMIC (v68) and data published in Harmful somatic amino acid substitutions affect key pathways in cancers is publicly available here. PON-P2 was the best performing method in a recent comparison and outperformed protein-specific predictors in 85% of the proteins (Riera et. al. 2016).NEWS: PON-P2 prediction for total Human Proteome is available here. |
'
![]() |
Home | News | Instructions | Disclaimer | Useful Links | Cancer variant predictions |
Predictions for somatic variations leading to amino acid substitutions using PON-P2.
Predictions COSMIC ALL AML Bladder Breast Cervix CLL Colorectum Esophageal Glioblastoma Glioma Low Grade Head and Neck Kidney Chromophobe Kideny Clear Cell Kidney Papillary Liver Lung Adeno Lung Small Cell Lung Squamous Lymphoma B-cell Medulloblastoma Melanoma Myeloma Neuroblastoma Ovary Pancreas Pilocytic Astrocytoma Prostate Stomach Thyroid Uterus |